User:Ivan E. Wang/Sandbox 1
From Proteopedia
(Difference between revisions)
| Line 11: | Line 11: | ||
== Enzymatic Catalyzed Reaction == | == Enzymatic Catalyzed Reaction == | ||
(PLACEHOLDER) | (PLACEHOLDER) | ||
| - | [[Image:Visual Cycle.jpg|thumb|left|alt=Figure 2: Human Visual Cycle| Figure 2: The canonical Visual Cycle in Humans <ref>DOI 10.1016/j.bbadis.2018.04.014</ref>]] | + | [[Image:Visual Cycle.jpg|thumb|left|512 px|alt=Figure 2: Human Visual Cycle| Figure 2: The canonical Visual Cycle in Humans <ref>DOI 10.1016/j.bbadis.2018.04.014</ref>]] |
Revision as of 23:03, 28 January 2020
Retinal Pigment Epithelium 65 (Retinoid Isomerohydrolase) complex with (R/S)-emixustat and palmitate
| |||||||||||
Contents |
Function
Structural Features of RPE65
(PLACEHOLDER)
Enzymatic Catalyzed Reaction
(PLACEHOLDER)
Protein-Ligand Interaction
Endogenous Ligand
(PLACEHOLDER)
Exogenous Ligand
| |||||||||||
| |||||||||||
R/S Enantiomers Differences
(PLACEHOLDER)
Disease Implications
(PLACEHOLDER)
Medical Relevance
(PLACEHOLDER)
This is a sample scene created with SAT to by Group, and another to make of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.
References
- ↑ Shin Y, Moiseyev G, Petrukhin K, Cioffi CL, Muthuraman P, Takahashi Y, Ma JX. A novel RPE65 inhibitor CU239 suppresses visual cycle and prevents retinal degeneration. Biochim Biophys Acta Mol Basis Dis. 2018 Jul;1864(7):2420-2429. doi:, 10.1016/j.bbadis.2018.04.014. Epub 2018 Apr 21. PMID:29684583 doi:http://dx.doi.org/10.1016/j.bbadis.2018.04.014
